Thomas Sciascia

USPTO Granted Patents = 13 (Patent Applications = 18)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 24(Granted Patents)

Company Filing History:

6 out of 7

Trevi Therapeutics Inc.

patents

6 out of 32

Endo Pharmaceuticals Inc.

patents

1 out of 11

Penwest Pharmaceuticals Company

patents

Years Active: 2013-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12274696 - Methods of administering nalbuphine (2025-04-14),

2. 11660296 - Treatment of chronic cough, breathlessness and dyspnea (2023-05-30),

3. 10406106 - Sustained release formulations of nalbuphine (2019-09-10),

4. 10238646 - Methods for treating pruritus (2019-03-26),

5. 10172798 - Sustained release formulation of nalbuphine (2019-01-08),

6. 9351938 - Sustained release formulation of nalbuphine (2016-05-31),

7. 9186330 - Sustained release formulation of nalbuphine (2015-11-17),

8. 8987289 - Methods for treating pruritus (2015-03-24),

9. 8940753 - Methods for treating pruritis (2015-01-27),

10. 8771732 - Sustained release formulations of nalbuphine (2014-07-08),

11. 8765175 - Sustained release formulation of nalbuphine (2014-07-01),

12. 8637538 - Methods for treatment of pruritis (2014-01-28),

13. 8394812 - Sustained release formulations of nalbuphine (2013-03-12),

Title: Innovations and Contributions of Inventor Thomas Sciascia

Introduction

Thomas Sciascia is a notable inventor based in Belmont, MA (US), recognized for his significant contributions to the field of medicine. With a total of 13 patents to his name, he has made strides in developing innovative methods for treating various health conditions.

Latest Patents

Among his latest patents, Sciascia has developed methods of administering nalbuphine. This invention provides methods for treating nalbuphine-treatable disorders in patients with hepatic impairment. Additionally, he has created methods for treating chronic cough, breathlessness, and dyspnea. This invention focuses on using nalbuphine compositions to provide therapeutic effects for patients suffering from chronic cough and related conditions.

Career Highlights

Throughout his career, Thomas Sciascia has worked with prominent companies in the pharmaceutical industry, including Trevi Therapeutics Inc. and Endo Pharmaceuticals Inc. His work has contributed to advancements in medical treatments and patient care.

Collaborations

Sciascia has collaborated with notable professionals in his field, including Anand R Baichwal and Philip A Goliber. These collaborations have further enhanced his innovative efforts and contributions to medical science.

Conclusion

In summary, Thomas Sciascia is a distinguished inventor whose work has significantly impacted the medical field through his innovative patents and collaborations. His dedication to improving patient care continues to inspire advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.